open access
Prevalence of hypertension among chronic smokers: findings from the early lung cancer detection programme MOLTEST BIS
- Department of Preventive Medicine and Education, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
- First Department of Cardiology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
- Department of Allergology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
- Department of Neurology of Adults, Faculty of Medicine, Medical University of Gdańsk
- Department of Thoracic Surgery, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
open access
Abstract
Abstract
Keywords
hypertension, smoking, chronic smokers, prevalence, risk factors
Title
Prevalence of hypertension among chronic smokers: findings from the early lung cancer detection programme MOLTEST BIS
Journal
Issue
Article type
Original paper
Pages
74-80
Published online
2018-06-12
Page views
1569
Article views/downloads
1024
DOI
Bibliographic record
Arterial Hypertension 2018;22(2):74-80.
Keywords
hypertension
smoking
chronic smokers
prevalence
risk factors
Authors
Aleksandra Rajca
Piotr Kasprzyk
Piotr Zieleniewicz
Aleksandra Undrunas
Adam Wyszomirski
Anna Nagórka
Marcin Ostrowski
Witold Rzyman
Tomasz Zdrojewski
- Zdrojewski T, Rutkowski M, Bandosz P. Ocena rozpowszechnienia i kontroli czynników ryzyka chorób serca i naczyń w Polsce — badania NATPOL 1997, 2002, 2011. In: Kopeć G, Jankowski P, Pająk A, Drygas W. ed. Epidemiologia i prewencja chorób układu krążenia. Medcyna Praktyczna 2015.
- Tykarski A, Posadzy-Małaczyńska A, Wyrzykowski B, et al. Rozpowszechnienie nadciśnienia tętniczego oraz skuteczność jego leczenia u dorosłych mieszkańców naszego kraju. Wyniki programu WOBASZ. Kardiol Pol ; 63: 6 (supl. 4). 2005; 63: 6(supl. 4): S1–S6.
- Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998; 316(7137): 1043–1047.
- Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004; 43(10): 1731–1737.
- Groppelli A, Omboni S, Parati G, et al. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens Suppl. 1990; 8(5): S35–S40.
- African Region WHO, of the Americas WHO, South-East Asia Region WHO, European Region WHO, Eastern Mediterranean Region WHO, Western Pacific Region WHO, et al. WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2017, Monitoring tobacco use and prevention policies 2017.
- Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis. 2012; 223(1): 1–68.
- Zdrojewski Ł, Zdrojewski T, Rutkowski M, et al. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol. 2013; 71(4): 381–392.
- Tykarski A, Narkiewicz K, Gaciong Z, et al. 2015 Guidelines for the Management of Hypertension Part 1–7. Polish Society of Hypertension. Arterial Hypertens. 2015; 19(2): 53–83.
- Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986; 111(5): 932–940.
- Berglund G, Wilhelmsen L. Factors related to blood pressure in a general population sample of Swedish men. Acta Med Scand. 1975; 198(4): 291–298.
- Seltzer CC. Effect of smoking on blood pressure. Am Heart J. 1974; 87(5): 558–564.
- Bang LE, Buttenschøn L, Kristensen KS, et al. Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives. Blood Press Monit. 2000; 5(5-6): 271–274.
- Mikkelsen KL, Wiinberg N, Høegholm A, et al. Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens. 1997; 10(5 Pt 1): 483–491.
- Najem B, Houssière A, Pathak A, et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension. 2006; 47(6): 1162–1167.
- Bovet P, Gervasoni JP, Ross AG, et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens. 2003; 21(3): 509–517.
- Nordahl H, Osler M, Frederiksen BL, et al. Combined effects of socioeconomic position, smoking, and hypertension on risk of ischemic and hemorrhagic stroke. Stroke. 2014; 45(9): 2582–2587.
- Centers for Disease Control and Prevention (CDC). Tobacco-Related Mortality; 2016 [page last updated May 15 2017]. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/tobacco_related_mortality/index.htm (May 15, 2018).
- Jassem J, Przewoźniak K, Zatoński W. Tobacco control in Poland-successes and challenges. Transl Lung Cancer Res. 2014; 3(5): 280–285.
- Giovino GA, Mirza SA, Samet JM, et al. GATS Collaborative Group. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012; 380(9842): 668–679.
- Flegal KM, Troiano RP, Pamuk ER, et al. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med. 1995; 333(18): 1165–1170.
- Huot I, Paradis G, Ledoux M, et al. Quebec Heart Health Demonstration Project research group. Factors associated with overweight and obesity in Quebec adults. Int J Obes Relat Metab Disord. 2004; 28(6): 766–774.
- Hofstetter A, Schutz Y, Jéquier E, et al. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med. 1986; 314(2): 79–82.
- John U, Hanke M, Rumpf HJ, et al. Smoking status, cigarettes per day, and their relationship to overweight and obesity among former and current smokers in a national adult general population sample. Int J Obes (Lond). 2005; 29(10): 1289–1294.
- Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA. 1989; 261(8): 1169–1173.